Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00472290
Status:
COMPLETED
Last Update Posted:
2017-12-29
First Post:
2007-05-10
Brief Title:
Evaluating the Safety of Long Term Dosing of Romiplostim Formerly AMG 531 in Thrombocytopenic Subjects With Myelodysplastic Syndromes MDS
Sponsor:
Amgen
Organization:
Amgen
Organization Data
Organization:
Amgen
Class:
INDUSTRY
Study ID:
20060197
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Amgen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None